PROTEIN-LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS
PROTEIN-LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS
批准号:
2145165
负责人:
Nezam Hassan Afdahl
金额:
$12.93万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-15 至 1996-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal of this research proposal is to define the
molecular mechanisms by which biliary proteins interact with
cholesterol vesicles in bile to promote cholesterol crystal
nucleation, crystal growth and gallstone formation. Cholesterol
gallstones account for 70% of gallbladder stones seen in the United
States and result in over 500,000 cholecystectomies annually with an
estimated health care cost in excess of $5 billion. Gallstone
formation is multifactorial and biliary proteins play a critical
role in the nucleation and growth of cholesterol monohydrate
crystals. Gallbladder mucin the major component of the mucus gel in
the gallbladder acts as the "glue" which binds plates of cholesterol
to form gallstones. Mucus hypersecretion may occur prior to
gallstone formation resulting in an ideal environment for the growth
of cholesterol crystals. Non-mucin proteins, such as biliary
immunoglobulins and aminopeptidase N, also promote cholesterol
crystal nucleation from supersaturated model and human biles. We
hypothesize that these poorly described protein-lipid interactions
are critical for cholesterol crystal nucleation and that nucleation
and growth preferentially occur in the mucus gel layer of the
gallbladder.
The specific aims of this proposal are to examine the effect of
biliary proteins on the earliest step in nucleation, the fusion or
lysis of cholesterol-phospholipid vesicles in model and human bile.
This will be achieved by fluorescent assays of vesicle fusion or
lysis and confirmation of morphological changes using biophysical
techniques such as light scattering and electron microscopy.
Comparison of these assays with nucleation time will determine if
vesicle-protein interactions are indeed the earliest events in
crystal formation and define the kinetics of nucleation. The effect
of mucin gels on vesicle diffusion and motion will be studied and
compared with synthetic gels to determine the unique properties of
mucin on cholesterol solubility and nucleation. Comparison of
vesicles to inert microspheres in mucin gels using dynamic and
forced Raleigh light scattering will differentiate between effects
of gel viscosity and vesicle fusion on movement through
physiological gels.Finally, cholesterol crystal growth in mucin and
synthetic gels will be examined by phase microscopy in a dynamic
model to identify the role of gels on crystal growth. The
cholesterol donors, in model and human bile, to crystal growth in
gels will be identified. These studies will determine the unique
interactions between bilary proteins and cholesterol vesicles in
solution and in gels and define their contribution to crystal
nucleation and gallstone growth perhaps leading to novel therapies
for the treatment and prevention of this common disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
-
批准号:7575791
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2008
-
负责人:Nezam Hassan Afdahl
-
依托单位:
CLINICAL TRIAL: PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER
-
批准号:7718934
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2008
-
负责人:Nezam Hassan Afdahl
-
依托单位:
PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER DISEASE
-
批准号:7606980
-
项目类别:
-
资助金额:$1.29万
-
财政年份:2007
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
-
批准号:7480347
-
项目类别:
-
资助金额:$35.84万
-
财政年份:2006
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
-
批准号:7275250
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2006
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
-
批准号:7123590
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2006
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
-
批准号:7667874
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2006
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
-
批准号:8128340
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2006
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Clinical Core
-
批准号:7013919
-
项目类别:
-
资助金额:$3.65万
-
财政年份:2005
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Proteomics and Biomarkers for Hepatocellular Cancer
-
批准号:6740691
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2003
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Proteomics and Biomarkers for Hepatocellular Cancer
-
批准号:6803571
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2003
-
负责人:Nezam Hassan Afdahl
-
依托单位:
NO Inhibition in Systemic/Renal Hemodynamics in Patients with Cirrhosis
-
批准号:7043349
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2003
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Antiviral Therapy in African Americans with HCV
-
批准号:6407035
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2001
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Antiviral Therapy in African Americans with HCV
-
批准号:6895832
-
项目类别:
-
资助金额:$10.5万
-
财政年份:2001
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Antiviral Therapy in African Americans with HCV
-
批准号:6647201
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2001
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Antiviral Therapy in African Americans with HCV
-
批准号:6765817
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2001
-
负责人:Nezam Hassan Afdahl
-
依托单位:
Antiviral Therapy in African Americans with HCV
-
批准号:6517972
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2001
-
负责人:Nezam Hassan Afdahl
-
依托单位:
PROTEIN LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS
-
批准号:6176189
-
项目类别:
-
资助金额:$23.12万
-
财政年份:1993
-
负责人:Nezam Hassan Afdahl
-
依托单位:
PROTEIN-LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS
-
批准号:2145164
-
项目类别:
-
资助金额:$14.35万
-
财政年份:1993
-
负责人:Nezam Hassan Afdahl
-
依托单位:
PROTEIN LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS
-
批准号:6517253
-
项目类别:
-
资助金额:$24.53万
-
财政年份:1993
-
负责人:Nezam Hassan Afdahl
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新肿瘤靶标 DHCR24/Lipid-Rafts 轴在急性髓系白血病中的作用和分子机制研究
-
批准号:LQ22H080007
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:吴照星
-
依托单位:
4-胺基阿拉伯糖基修饰的活性寡糖分子lipid A及衍生物的合成研究
-
批准号:22007080
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:朱玉根
-
依托单位:
CRISPR/Cas9基因编辑 PLGA/Lipid纳米可视递送系统靶向治疗骨关节炎的作用机制研究
-
批准号:2020A151501615
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:于博
-
依托单位:
CRISPR/Cas9基因编辑PLGA/Lipid纳米可视递送系统靶向治疗骨关节炎的作用机制研究
-
批准号:81974323
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:于博
-
依托单位:
超声示踪载药PLGA/Lipid复合纳泡修饰的BMSCs及其调控修复骨质疏松性骨损伤的研究
-
批准号:81871355
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2018
-
负责人:陈彦
-
依托单位:
可穿透胰腺癌双重屏障的肿瘤微环境响应型多级HSA/lipid纳米递药系统研究
-
批准号:81703010
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:魏彦
-
依托单位:
革兰阴性菌中合成Kdo2-Lipid A的蛋白质反应机理研究及抑制剂筛选
-
批准号:31370731
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2013
-
负责人:姚闵
-
依托单位:
以lipid A 为靶点的黄连解毒汤抗内毒素的物质基础及作用机制研究
-
批准号:81303205
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:陈桂荣
-
依托单位:
lipid raft/caveolae调节PMVECs接触性抑制在肝肺综合症肺微血管扩张中的作用和机制研究
-
批准号:81270510
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2012
-
负责人:鲁开智
-
依托单位:
Lipid rafts调控干燥综合征唾液腺上皮细胞凋亡信号的分子机制
-
批准号:30671948
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:李萍
-
依托单位: